R&D software for cosmetic manufacturers

Excel is the default cosmetic formulation tool because it's fast for one chemist. It collapses the moment a second formulator opens the file, a regulator asks who approved version 14, or a market expansion requires the same formula filed in five jurisdictions. Worldover replaces the spreadsheet with an audit-ready record where every change is attributable, every ingredient carries its INCI, CAS, allergens and restriction limits, and every approval is signed and time-stamped.

For regulatory and R&D leaders, the practical answer to "what software is best for cosmetic formulation instead of Excel?" is a system that closes the gap to regulatory work, not one that recreates the spreadsheet in a nicer UI. That's what Worldover is built to do.

Every formula is screened live against US MoCRA, EU 1223/2009 (Annexes II to VI), UK SCPN rules, the ECHA SVHC candidate list and CLP CMR categorisations as it's built. Restriction limits, prohibited substances and concentration thresholds are evaluated per market, not buried in a PDF a regulatory manager has to interpret by hand.

When a regulation changes (a new SVHC addition, a revised Annex III entry, a MoCRA fragrance allergen update) Worldover propagates the impact across every dependent formula, flags the affected SKUs and routes the work. See cosmetic and chemical compliance software for the full regulatory engine.

Formulas, packaging components and on-pack claims are versioned together, not in three different folders. Each customer-specific variant is a controlled fork of the master formula, so a change to the master can be propagated, reviewed and approved across every dependent variant with full lineage. Approval workflows, electronic signatures and audit trail are native to the record, which means an FDA, ANSM or OPSS request is answered in minutes, not weeks.

Lab notebook entries, stability and challenge testing, claim evidence and supplier certificates all attach to the same formula record. When the formula is approved, the PIF and CPSR exist by definition. CPNP, SCPN and MoCRA filings generate from the same record, so a launch into a new market is a propagation step, not a six-week re-keying project.

Brands get formulation control without standing up a lab system. Manufacturers get private-label fork management without copy-paste chaos. Both reach launch with a single source of truth that connects R&D, regulatory, supply and commercial. To see the operational layer downstream of formulation, read about cosmetic ERP software, or see how Iconic London uses Worldover to run formulation, regulation and operations from one system.

Most tools in this category demo well. The differences show up in month four, when the second market opens or a supplier changes a grade. These are the questions that separate them.

1. Is INCI a dictionary or a text field? If ingredient names are free text, every downstream check, label and filing is unreliable by design.
2. Are restriction checks live against current Annexes, or a static list someone loaded at implementation and now maintains by hand?
3. Does a regulatory change propagate backwards? When a substance is restricted, can the system tell you every formula, SKU, market and customer affected, in one query?
4. Does it handle the 0.001% and 0.01% allergen thresholds for leave-on and rinse-off automatically, including allergens arriving through fragrance compounds and raw material impurities?
5. Can it fork a master formula into customer or market variants with lineage, so a change to the master can be reviewed and propagated rather than copy-pasted?
6. Is the packaging component versioned with the formula? Compatibility, stability and market-specific packaging marks depend on it.
7. Does it generate the PIF and CPSR, or does it export data that someone then assembles into a document?
8. Are electronic signature and audit trail native to the record, with 21 CFR Part 11-style controls, or bolted on through a document system?
9. How many markets are supported natively? EU 1223/2009, UK, US MoCRA, China, ASEAN, Mercosur and the Gulf states have materially different rules; multi-market support in a brochure often means one market plus a spreadsheet.
10. Does it reach production? A formula record that isn't also the manufacturing bill of materials guarantees the drift between what was approved and what is made.
11. What is the real cost of ownership? Licence, implementation, data migration, per-market modules, integration and the internal headcount required to keep it current.

• Weeks 1 to 2, raw material master. Consolidate the ingredient list to unique raw materials with supplier, grade, INCI breakdown and CAS numbers. This is the step that determines everything after it, and the step teams try to shorten.
• Weeks 2 to 4, formula import. Active formulas load first. Historical versions come across as read-only lineage rather than being rebuilt.
• Weeks 4 to 6, regulatory baseline. Run the whole portfolio against current Annexes, the SVHC candidate list and CMR categorisations. Expect findings. Most teams discover a handful of legacy issues here, which is the point.
• Weeks 6 to 8, documents and workflow. PIF and CPSR templates, approval routes, signature rules and permissions.
• Weeks 8 to 12, parallel run and integration. New development goes into the system while existing launches finish on the old process. ERP and manufacturing links go in here.

Three things reliably decide whether this takes twelve weeks or nine months: the state of the raw material data, whether one person owns the migration, and whether historical versions are migrated or archived. Archive them.

Formulation tools demo well and differ enormously in what they leave you doing by hand. These are the eight criteria worth scoring, with what a good answer looks like.

A single demo question separates most vendors: change one raw material on a formula used in twelve finished goods, and show me every document and every market that just became out of date.

Formulation software isn't the only reasonable answer, and it's worth being honest about when it isn't the answer.

The honest framing: if your regulatory work ends at the INCI list, a formulation tool alone is enough. If a formula change has to propagate to a PIF, a CPNP frame formulation, a Safety Data Sheet and a customer declaration, the boundary between formulation and documentation is where the cost sits, and a tool on either side of that boundary leaves it with you.

One SPF 30 daily moisturiser, EU and GB launch, showing where each regulatory check fires.

1. Brief. Target markets, claim set and price point recorded against the project. The claim set matters now, not later, because it determines what substantiation the PIF will need.
2. First trial formula. As percentages are entered, Annex VI UV filter limits evaluate live. The chosen filter combination is checked against both the EU and GB lists, which is where a GB-only divergence would surface.
3. Preservative system. Annex V limits check on entry, with the phenoxyethanol level flagged against its 1% ceiling and the combined system reviewed for challenge testing.
4. Fragrance. The supplier's allergen breakdown rolls up through the compound to a finished product level, and the 26 declarable allergens above 0.001% for leave-on are identified automatically for the INCI list.
5. Impurity screen. Raw material specifications are screened for Annex II substances present as impurities, and against the SVHC candidate list for supplier declaration purposes.
6. Stability and compatibility. Test results attach to the formula version, not to the product, so a later reformulation can't inherit a previous version's stability data.
7. Formula freeze. The version is locked, and the frame formulation for CPNP and the quantitative formula for the PIF generate from it.
8. Safety assessment. The assessor receives the composition, exposure data, impurity profile and test results as a compiled Annex I Part A pack rather than a request for eleven attachments.
9. Claims. Each claim maps to its evidence under the Regulation 655/2013 common criteria, and unsupported claims block the file rather than being caught at artwork.
10. PIF assembly and notification. The five Article 11 parts assemble from live records, CPNP and SCPN notifications submit against the same frame formulation, and the file is attributable to the specific pack from day one.

The point isn't that the steps are unusual. It's that each check fires at the moment the decision is made rather than three months later, when changing it costs a relaunch. See the Product Information File guide for what the finished file has to contain.